Shareholding21 Sept 2026, 03:23 pm
Max-Bio Biosciences Acquires 11.89% Stake in Raconteur Global Resources
AI Summary
Max-Bio Biosciences Private Limited has disclosed a substantial acquisition of shares in Raconteur Global Resources Limited. The acquisition, executed via Preferential Allotment, resulted in Max-Bio Biosciences holding 11.89% of the total diluted share capital, amounting to 2,142,857 shares. This move signifies a significant stake increase by Max-Bio Biosciences in Raconteur Global Resources, with the transaction details filed under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
Key Highlights
- Max-Bio Biosciences acquired 11.89% stake in Raconteur Global Resources.
- The acquisition involved 2,142,857 shares.
- The mode of acquisition was a Preferential Allotment.
- The filing is in accordance with SEBI (SAST) Regulations, 2011.
- This represents a substantial acquisition of shares.
Price Impact
More from RACONTEUR